cas 1628338-77-1|| where to buy 3-(2-(6-(tert-Butyl)-1H-benzo[d]imidazol-2-yl)ethyl)cyclobutanonehydrochloride

Nom du produit:3-(2-(6-(tert-Butyl)-1H-benzo[d]imidazol-2-yl)ethyl)cyclobutanonehydrochloride

IUPAC Name:3-[2-(6-tert-butyl-1H-1,3-benzodiazol-2-yl)ethyl]cyclobutan-1-one hydrochloride

: CAS：1628338-77-1; Formule moléculaire：C17H23ClN2O; Pureté：95%+

Unité d'emballage	Stock disponible	Prix($)
CM416205-100mg	in stock	Ůħ
CM416205-250mg	in stock	ƴĳŮ
CM416205-1g	in stock	ħƈħ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1628338-77-1 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1628338-77-1; Formule moléculaire:C17H23ClN2O; Point de fusion:-; Code SMILES:Cl.CC(C)(C)C1=CC2=C(C=C1)N=C(CCC1CC(=O)C1)N2; Densité:

: Numéro de catalogue:CM416205; Poids moléculaire:306.83; Point d'ébullition:; N° Mdl:; Stockage:

: Benzimidazoles; Benzimidazole is a benzo derivative of imidazole. It is a kind of bicyclic aromatic organic compounds, which is formed by fusing a six-membered benzene ring and five-membered imidazole at positions 4 and 5 of imidazole ring. It is an important pharmacophore of many biologically active heterocyclic compounds with various pharmacological activities. Benzimidazoles and their derivatives have developed into dynamic heterocyclic systems due to their potency in a variety of biologically active compounds such as anticancer, bactericidal and antiviral drugs. Benzimidazoles are a class of therapeutic motifs with broad relevance in medicinal chemistry.

: Cyclobutanes; The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.